Your browser doesn't support javascript.
loading
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
Moore, Graham J; Ridgway, Harry; Kelaidonis, Konstantinos; Chasapis, Christos T; Ligielli, Irene; Mavromoustakos, Thomas; Bojarska, Joanna; Matsoukas, John M.
Afiliación
  • Moore GJ; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Ridgway H; Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.
  • Kelaidonis K; Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, VIC 8001, Australia.
  • Chasapis CT; AquaMem Consultants, Rodeo, New Mexico, NM 88056, USA.
  • Ligielli I; NewDrug PC, Patras Science Park, 26504 Patras, Greece.
  • Mavromoustakos T; NMR Facility, Instrumental Analysis Laboratory, School of Natural Sciences, University of Patras, 26504 Patras, Greece.
  • Bojarska J; Institute of Chemical Engineering Sciences, Foundation for Research and Technology, Hellas (FORTH/ICE-HT), 26504 Patras, Greece.
  • Matsoukas JM; Department of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Molecules ; 27(15)2022 Jul 29.
Article en En | MEDLINE | ID: mdl-35956801
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2022 Tipo del documento: Article